Bon Natural Life Ltd (BON) stock
BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30
$1.07−0.02 (-1.83%)
Close on Nov 17, 2026Market cap $8.70MP/E –Yield –
Bon Natural Life price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Bon Natural Life's price to sales ratio was 0.2× on Nov 11, 2026, against 0.0× a year earlier. Over the last 5 years it ranged from 0.0× to 421.5×, with a median of 4.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.2× | −0.1 |
| 2025 | Dec 31, 2025 | 0.2× | −7.1 |
| 2024 | Dec 31, 2024 | 7.4× | +2.0 |
| 2023 | Dec 29, 2023 | 5.4× | −68.8 |
| 2022 | Dec 30, 2022 | 74.2× | −289.3 |
| 2021 | Dec 31, 2021 | 363.5× | – |
See a number that looks wrong?